Quality of Life and Meaning of Illness of Women With Lung Cancer
ABSTRACT To describe the quality of life (QOL) of women with non-small cell lung cancer (NSCLC) and examine relationships of demographic, clinical, health status, and meaning of illness (MOI) characteristics to QOL.
Descriptive, cross-sectional survey.
In-person interviews in homes or research offices.
217 women with NSCLC (greater than 6 months and less than 5 years since diagnosis, mean = 2 years); 19% of the women had advanced disease. The mean age was 65 years.
Assessments of QOL with cancer-specific (QOL Scale-Patient Version) and generic (Short Form-36) self-reports, health status (i.e., number and type of comorbid conditions, presence of depressed mood using the Center for Epidemiologic Studies Depression Scale, smoking status), and MOI (positive and negative perceptions).
QOL, health status, MOI, and demographic and clinical characteristics.
Serious disruptions in psychological and social aspects of QOL were common. Depressed mood, negative conceptualizations of MOI, and younger age explained 37% of the variance of global QOL and were correlated with poorer physical, psychological, and social dimensions of QOL. Thirty-six percent reported negative ascriptions of MOI; 35% experienced depressed mood; more than 75% reported distress with their diagnosis, family distress, and impact of sexual function as lowering their QOL; and 67% reported comorbid conditions, the most common being chronic obstructive pulmonary disease (31%).
Women with lung cancer experience a range of disruptions in QOL, and more than a third associate lung cancer with negative meaning. Younger age, depressed mood, and number of comorbid diseases are risk factors for negative QOL.
These findings support the importance of assessing the QOL, MOI, and health status of women with lung cancer even after treatment is completed. Younger women may be at higher risk for disruptions.
- SourceAvailable from: Janine K Cataldo
[Show abstract] [Hide abstract]
- "The possibility exists that this sample sought out an online support group because of depression. However, as a result of a lung cancer diagnosis, patients often experience increased psychological distress (Bottorff et al., 2009; Henoch et al., 2007; McBride et al., 2003; Sarna et al., Jan 2005). Because lung cancer patients experience more psychological distress than other cancer patients, stigma intervention and mood management needs to be an essential aspect of treatment. "
ABSTRACT: In 2010, lung cancer is expected to be the leading cause of cancer death in both men and women. Because survival rates are increasing, an evaluation of the effects of treatment on quality of life (QOL) is an important outcome measure. In other diseases, stigma is known to have a negative impact on health status and QOL and be amenable to intervention. This is the first study to compare levels of lung cancer stigma (LCS) and relationships between LCS, depression, and QOL in ever and never smokers. A total of 192 participants with a self-report diagnosis of lung cancer completed questionnaires online. Strong associations in the expected directions, were found between LCS and depression (r = 0.68, p < 0.001) and QOL (r = -0.65, p < 0.001). No significant differences were found in demographic characteristics or study variables between ever smokers and never smokers. A simultaneous multiple regression with 5 independent variables revealed an overall model that explained 62.5% of the total variance of QOL (F5,168 = 56.015, P < 0.001). After removing age, gender, and smoking status, depression explained 22.5% of the total variance of QOL (F4,168 = 100.661, p < 0.001). It is expected that depression and LCS would share some of the explanation of the variance of QOL, the correlation between LCS and depression is 0.629 (p < 0.001), however, LCS provides a unique and significant explanation of the variance of QOL over and above that of depression, age, gender, and smoking status, by 2.1% (p < 0.001).European journal of oncology nursing: the official journal of European Oncology Nursing Society 07/2011; 16(3):264-9. DOI:10.1016/j.ejon.2011.06.008 · 1.79 Impact Factor
[Show abstract] [Hide abstract]
- "109 Mixed Cross-sectional study on prevalence and correlates of intensity of supportive care needs High prevalence of unmet needs in the physical, daily living and psychological domain. Higher levels of supportive care needs are associated with more difficulties regarding the illness Sarna 2005 USA  "
ABSTRACT: This study examined quality of life (QOL) and illness perceptions in Dutch and Japanese patients with non-small-cell lung cancer, thereby extending the body of knowledge on cultural differences and psychosocial aspects of this illness. 24 Dutch and 22 Japanese patients with non-small-cell lung cancer filled out questionnaires on three occasions: immediately before chemotherapy, 1 week later, and 8 weeks after the initial chemotherapy. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) assessed QOL, and the Brief Illness Perception Questionnaire (B-IPQ) illness perceptions. Scores on several QOL measures indicated (a) major impact of first chemotherapy sessions, and (b) some tendency to returning to baseline measures at 8 weeks. Differences between Japanese and Dutch samples were found on five EORTC QLQ-C30 dimensions: global health status, emotional functioning, social functioning, constipation, and financial difficulties, with the Dutch patients reporting more favorable scores. Regarding illness perceptions, Japanese patients had higher means on perceived treatment control and personal control, expressing a higher sense of belief in the success of medical treatment than Dutch patients. In both Japanese and Dutch patients, impact of chemotherapy on QOL was evident. Some differences in illness perceptions and QOL between the two samples were observed, with implications for integral medical management. Both samples reported illness perceptions that reflect the major consequences of non-small-cell lung cancer. Incorporating symptom reports, illness perceptions, and QOL into medical management may have positive consequences for patients with non-small-cell lung cancer.Lung cancer (Amsterdam, Netherlands) 10/2010; 72(3):384-90. DOI:10.1016/j.lungcan.2010.09.010 · 3.74 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Los problemas psicosociales son parte natural de la persona que sufre de cáncer. La palabra cáncer de por sí trae consigo misma temor y produce altos niveles de incertidumbre, lo cual genera altas demandas para los pacientes y sus familias. Virtualmente todos los pacientes que se diagnostican con cáncer tienen una respuesta inicial de malestar, estrés o perturbación emocional. Se ha establecido que entre un 30% y un 50% de las personas con cáncer presentan alguna alteración psicológica que amerita tratamiento. En el año 2006 se diagnosticaran aproximadamente 174.470 casos nuevos de cáncer de pulmón y 162.460 muertes a causa de esta patología. El cáncer de pulmón es uno de los cánceres más comunes en el mundo industrializado. Los pacientes con cáncer de pulmón comúnmente experimentan síntomas de malestar y disminución en su funcionamiento físico con relación a la enfermedad y el tratamiento. El impacto de estos fenómenos puede verse reflejado al evaluar el estado emocional y la calidad de vida de los pacientes. La depresión y la ansiedad son los trastornos más frecuentes y muchas veces no son atendidos. Los pacientes que tienen dificultad en adaptarse representan un claro reto para el equipo clínico, ya que el mismo equipo se ve en la necesidad de responder a múltiples problemas psicológicos y sociales. Este artículo hará una revisión general de los aspectos psicosociales del paciente con cáncer de pulmón incluyendo aspectos sintomáticos, familiares, calidad de vida, culpabilidad, tabaquismo y supervivientes a largo plazo. Psychosocial issues are a natural component of a cancer patient. The word cancer by itself brings a high level of uncertainty and fear, which generates high demands for the patient and his family. It has been established that 30-50% of patients with a cancer diagnosis have a significant degree of distress that requires treatment by professional staff. Approximately 174,470 newly diagnosed Lung cancer cases, and 164,460 deaths cause by this disease are expected in the year 2006. Lung cancer is one of the most common causes of cancer in the industrialized world. Lung cancer patients commonly experienced symptoms of distress and decrease in physical functioning related to the treatment and the disease itself. The impact of this phenomenon can be reflected in their emotional well being and their quality of life. Depression and Anxiety are the most frequent disorders present in these patients, unfortunately, very often, they are ignored and not treated. Patients that have difficulties adjusting to their new situation clearly represent a challenge to the treatment team. This article reviews the general psychosocial aspects of then lung cancer patient including aspects such as: symptoms distress, family distress, guilt and tobacco, quality of life and survivorship.